Drugs / Amoxicilline/clavulanate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00717561 Comparator | Feb 2008 → May 2009 | pneumonia | Bayer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amoxicilline/clavulanate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00717561 ↗ |
| Route | Oral | “Oral therapy: every 8 hours patients will be administered a 1000 mg amoxicillin/clavulanic acid tablet” NCT00717561 ↗ |